Menu
GeneBe

RBMS3

RNA binding motif single stranded interacting protein 3, the group of RNA binding motif containing

Basic information

Region (hg38): 3:28574790-30010391

Links

ENSG00000144642NCBI:27303OMIM:605786HGNC:13427Uniprot:Q6XE24AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RBMS3 gene.

  • Inborn genetic diseases (13 variants)
  • not provided (9 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBMS3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
3
clinvar
5
missense
13
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
4
4
non coding
0
Total 0 0 13 2 3

Variants in RBMS3

This is a list of pathogenic ClinVar variants found in the RBMS3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-28769096-CCTCATAGAGCTATTCAATTTCTTTTTTAAGAATGACAGGTATATAATACAATGGGTACACAATATAAATTTTCTAAATAGAGCCAATTTTTTCTACCATTATTATAAAGAACACAACTCCTCTTGACACAGACACAAACACTCACACATTTCAAAGAGAAGTCCATTAAAAACAACAACAGAACTGGGGAGAACAGTGGGACATTATTTAACACCAGTCTGTGTACCCCCGATTCAGGGATTACTGGGAATGTTAAGCCAATTATTTTTTTAAGCCAATGTATTTAATCAGAGACTTAGAGTAAATAACACTAGATTTTTACAATATTAGTAGAATTCTCTTCCTGCTGTCTTTTGTGCTCAGCCATTTTTTTCTATAAGTGACTGACCTTATTGTGCAACTCACTGGAATAATCCCTGTAAAAAATGTTAAAGGATAAACACTATTTGGAAGCTTTTTAATAATTTTAGAATCCTTTAAATCCTTTAGAACTTCTGCATAACATTTTAGGCTTTACTTGGTCTGACTCTTGTGACTGCTGGGACTTTCTATGTGACTAAGTAATCAGATAAGATTATTAATTTGTTGATAAATGACAAAAACGTAACATACCATTTTTCTCAGATTAAAAATTTTAATTTAGCCACTATGGCCTTAAAACACAGAATAGTTAATGAATCATAGTATTATTTGACATAGTATATGTGTATTTTGCCTCAAACATATGCTGGTACCTATGCTAAAATCAAAGACAAGTGGGTAATAGTCTATGACTTTAAAAGATCACAGTCTGAACTCCAGTAAAGTCTCAGGGAGGAAATTTTAAGAATTGTCATTGACCACTTAATTCCCTCTGCAGAGTTTTTCCCAGTGGTGATCCATCTTCCCTTAGAAATCCTCAGTGCCACTGTACTTGTTATCACTCATGGCAATCAATGCCATCTCTGGAGATCTCATCCTTATAGTCAGGTGAAAATCTATGTCTTGATGAGTTTATCCATGGATGGTATTTCTAACTTAGGAAATTCGAATGTCTACAAAGGCTTGGCAGATAATTTACATGAGCTAGGCAAGCCAGGTATTAAAATTTAAAAGTTCAAGTATTATAAAAAATGGCATAAGGCATGTGACCAGAGCATGGTGAAGACAATAGTTGTGTGGTAGGGACTGTGGTCAAAACTGAAAAGCATGCCATCTTTCACTGTCATTTATTGTTTTTTTGAAGAAATGTGGGCCAGATATTATAATTTTTTTCAAGAAAACCGGAATTTGGCAGCTTTATTTGGCGTCTCCTGATTTTTAAATTGGCAACTGATTCAAAACTTTTAAGACATTCTGGGGGACAACATTTTGAGAGACAAGCACATATCTACAGCTAGATTTGGCCTGTAGGCTATTAATTTTTAAAACTTTTCTAAACGCTACAGGTATAAGAAATAAACCTATATTCTCCTTCACTTGAAAGATTCTATGGTTAATACTACGTGTCAACTTGATTGGATTGAGGGATGCCTAGATGTCTGGTAAAGTATTGGTTTTGGGCGTCTTTGTGAGGGTGTTGCCAGAGGAAATTAAGTTGGTGCCCTGGGAGAGGAAGACCCGCCCTTAATGTGGATGGACACCATCCAATCAGTTGCCAGCATGGCTAGAACAAAGCAGGTGGAAGAATGTGGGATAAGTTCTTGCTGAGTCTTATGGGTATCTTCCTTCTTCCTGTGCCAGATGCTTGATTCTGCTCCTCCTGCCCTTGGACATCAGTCTGCAGGTTCTTTAGCCTTTGGACTCTGGGACTTGCATTAGCAGCTTCTTTGGGACTCTTGGACCTTTGGCCACAGAATGTTTGCTTCTCTGGTTTTGATGCTTTCAGACATGGACTGAACCACTATCAGCTTCTCTCTTTCCCCAGCTTGCAGGTGGCCTAGTACAGAAAATTGGTACTGGGTGGTAGGACATTGCTATTAAGATACCTGAAAATATGGACTTGACTTTGGAACTGGGTAATGGGCAGAGGTTGGAAGAGTTTAGAGTGCTCAGAAGAGGACAAGAAGATGAAAGAAAGTTTGGAACTTCTTAAGAAACTGGTTAAATGGTTGTGACCAAATTGCTGATAGTGATAGGGACAATGAAGTCCACGTCTCAGATGGAAATGAGGAACTTATTGGGAGCTGGAGAAAAGGTTTCACATGTCATTCCTTAGCAAAGAGCTTAGCTGCATTCTGTTTATGCCCTGGGGATCTATGGAAGTTTGAACTTCATAGTGAAGATTTAGGGTATCTGATGGTAAAAAAAACTTCTAAGCAGCAAAGCATTCAAGATGTAGCCTGGGCACAGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGGGGGGCGGATCACCTGAGGTCAGGAGTTCAAGACCAGCCTGGCTAACATGGCAAAACCCTGTCTCTACTAAAAATACAAAAATTAGCCAGGTGTGGTGGCATACACCTGTAGTCCCAGCTAGTCAGGAGGCTGAGGCAGGAGAATTGCTCAAACCTGGGAGGTGGAGGTTGCAGTGAGCCAAGATTGTGCCATGACACTCCAGCCTGGCCAGCAGAGTGAGTCTCCATCTTAAAAAAAAAAAAAAAAAAAAAATATGTGGCCTGGCTTCTTCTAACAGCCTATACTCAGATGTAGGAGCAAAGAAATATCTTAAAGTTGGAACTTATATTTAAAAAGGAAACAGACATAAAAATTTGGAAAACCTGCAGCCTAGCCAGGTGGCAGAGAAAGGAAAAGCTTTTTCAGGAGAGAAATTCAAGCAGGCTGAGGAGCAACCACTTGCTGAAAACATTTGCATAACTAAAAAAGGGAGCCAAGTGCTGATAGTCAAGACAATGGGAAAAAGGCCTGGAAGACATTTTGGAGAACTTCATGATGGCTCCTCCCATCATAGGCCCCAAGGCATAGGAAGGAAAGAATGGTTTCCCAGACCAGGCCTGTCAGGACACTGCTCCCTGCATCTTAGCTACTCTGGCTCCAGACCTGGTTCAAAGGGCCCAAGATACTGTTCGTGCTGCCACACTGGAGAGTGCAAGCTGCCATAAGGCTTGCTAGCTTCCACATGTTGTTAAGCCTATGGGCACACAGAGTGGGAGAGTAAAAGAGCTTGGCACCATCTGTCTAGATTTCAGAAGATGTATGGAACAGACTGTGTGTCCAGACAGAAGTGTGCTGCAGGGGTGGACCCCTGACTAGGAGTACCCAGTGGGTCACTGCCTGGTGGAGATGTGAGAAGAGGGCCACTGTCCCTAGATCCCAGAGTGTTAGATCCTCTCTGCCTGTGTCCACAGTTCTGTGCCAGGTCTTATGATAGCAGCTGTAGGGGCTGCATCTTGCACAGCCACAGGTGCAGAGCTACCCAAGTGGGCGAAGAGCCCACTTCTTGCACCAGTGTTCCCTGTATGTGGGACATGGAGTCAAAGAAGATTAGAGCTTTAAGATTTAATGACTGCCTTGTTGGCTTTCAAACTTGCATGGGGCCTGTAGCCCCTTTATTTTGACTGGTTTCTCCCTTTTGGAATGGGAATGTTTACCTAATGCCTATACCCAGATTGTATCTTGGAAGAAATTATCTTCTTCTTTATTTCACAGTCTCATAGATGGAAGAAATTTGCCTTGTCTCAGATGAGACTTTGGATTTTGGACTTTTGACTTCTGAATTGACAAGAATGAATTAAGACTTTGGGGGACTGTTAGGAAGGCATGATTGTATTTTGCAATGTAAGAAAGACTTGAGATTTGGGGGGGCCAGGGATGGAATAATATAGTTTGGATATTTGTCCCCACCCAAATCTCATATTGAAATGTAATCCCCAATGCTGGACATGGGCCCTGGTGAGAGGTATTTTTATCATGGGGGTGGATGCATCATGAATGGCTTGGGCCGTCCCCTCGGTGTTAAGTGAGCTCTCATTCTGGGTTCACACAAGATCTGGTCATTTAAAAGTGTGTGCCTCCCTGCCATCCCCGATACACACACACTATCTCTCTTGCTCTTGCTCACTCCTGCCTTCTCCATGTGATGTGCCTGCTCCCTGTTCAAGGGTGATATTTGGAAAACATTTGCCAAACTGTGTTTCCTACCTGTGTAAAGAGCTACTCTTCCAAAAGACTGTCAGAGCACCAGTATAAACCCAACTCTTACTGAATAGTGGAAATTTCAGACTGAGACAGAAAATATTTGGGGAAAGATTTCCCCAAATCACTCACCAATTATATCTACATATGACTTTAATTAGATAAAATGCCTAGTCCAGTGTCATCTTCTTACATGAATGTCCAATAAATGTTTATTTCCATTGCTGGTTGTTCTCCATTTAACTCCCCACCTAGACCCACTATCTGCCCTTATGCCCCTGATTTGGAACACTGAAGGCTGACTCCTCTGCACTGCAATATTTGGGTTCCCTTGCCACATGGCTTCCAGTAGGGTATGGCCAAGGGAAGACACCAGAAAGATATCAGAGAGCAGAAGGAGAGAGAAGCCAGGCTATTTATTCCATGTTCCCTCCCTACTTTAAATTTCCATCTCTAATAGTAGCTGCATCTCTGTATGATTTCAGATTCTACTAGAGAGCCTGTCTGCCATAAGTCTCTGGTAGAATCTGAGATCATACAGAGAGATAGAAACACATCTCTCATGGAGCCCCTGAAATGTTCATTTTAACCTGTTACTTCTTTGACTCCAAAGATGGTAACAGATTCCCAATGTTGCTAATGTCTGAGTGCCTCAACTCTTGCCAAGTACCTTTGTCTCTTGATTAGAAATGTTTGGGGTGAATTGTTTATTCTGCAGTGTTCTCTGGGAGACACATTCTCCTTCCCTTTCTCCTTAGCCCTTATAATGCCATTTCTCCATTTATCTCTGTGTCAATGATAGCAACTTGTCTTTAATGAAAGGTGTTTAAATATGTGGTTAGTAATATTCAGTCATATTTTTCAGTTTCACTGTCTTGATGAGTGTCAGGATCTTCTTGGATAAGTCACTCTCTACAGAACCATGTTTAAAATTACAAAAAACTACCCTGTTGATCCACAGAGCACAAGAACATGTTAATTACTGTATAGAGGTAGCCTGCTATTTCCAGCACGCTCAAGTGAAGCCTCTGAGCCTCCAGAAGCCTTAGCTGTTTCTATTTTCTGAACCAGATTTGACCACCTGGGATGTATTGGAAGCTTTATTCTCACCAGCAGGATAGGTGTGGAACTAGTCTTATTCTTCTTACCCCTGTTTTCAGTGAGCTTCAAGAGATGCCTATGAAACCAAACCTAACTACAATTTCTACATTATGGGTCTGCCCCTTTATAATTTCAGTCATGCCTTGGAGACATTTTCCAGGTTACACAAACTTCTCAGAACCATAGCACTGCCAACCTACCTAATCTCAAGTATTTTGATCTGGGTGAATTTTTGATTCATGTTTCTTAGAGTACTTTGGAATTTGGTCCTCTGACCACCTACCA-C Gestational diabetes mellitus uncontrolled not provided (-)156844
3-29281722-A-G not specified Uncertain significance (Sep 28, 2022)2314236
3-29281736-C-T not specified Uncertain significance (Oct 25, 2023)3152487
3-29434786-C-T not specified Uncertain significance (Mar 08, 2024)2231765
3-29434823-C-G not specified Uncertain significance (Apr 06, 2022)2281336
3-29434860-A-G not specified Uncertain significance (Jun 07, 2023)2511212
3-29434885-C-G not specified Uncertain significance (Jan 24, 2023)3152483
3-29434890-C-A not specified Uncertain significance (Dec 20, 2023)3152484
3-29434899-A-G not specified Uncertain significance (Sep 26, 2023)3152485
3-29434900-T-A not specified Uncertain significance (Sep 26, 2022)2356025
3-29739823-C-G not specified Uncertain significance (Aug 17, 2021)2246310
3-29739836-A-G Likely benign (Apr 05, 2018)777963
3-29739843-G-A not specified Uncertain significance (Jan 23, 2024)3152486
3-29762904-T-A Benign (Mar 31, 2018)770884
3-29762918-C-G not specified Uncertain significance (Jun 28, 2022)2298511
3-29762949-T-C Benign (Mar 29, 2018)780379
3-29762962-T-C not specified Uncertain significance (Dec 18, 2023)3152488
3-29884215-A-G Benign (Mar 01, 2018)736820
3-29897394-G-A Benign (Mar 29, 2018)727793
3-29897413-C-T not specified Uncertain significance (Dec 21, 2023)3152489
3-29899722-G-T not specified Uncertain significance (Dec 14, 2022)2335054
3-29936079-C-T Benign (Apr 06, 2018)722575
3-29936106-C-T Likely benign (Dec 31, 2019)754613
3-29936123-C-T not specified Uncertain significance (Mar 07, 2023)2495376
3-29936183-G-A not specified Uncertain significance (Aug 31, 2022)2309928

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RBMS3protein_codingprotein_codingENST00000383767 15729414
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2130.7871257180281257460.000111
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.271852410.7690.00001182864
Missense in Polyphen76117.990.644141417
Synonymous0.7517684.80.8960.00000476805
Loss of Function3.78728.90.2420.00000147317

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001130.00113
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00004490.0000440
Middle Eastern0.000.00
South Asian0.00009800.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds poly(A) and poly(U) oligoribonucleotides. {ECO:0000269|PubMed:10675610}.;

Recessive Scores

pRec
0.108

Intolerance Scores

loftool
0.749
rvis_EVS
-0.6
rvis_percentile_EVS
17.75

Haploinsufficiency Scores

pHI
0.610
hipred
Y
hipred_score
0.649
ghis
0.668

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.427

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rbms3
Phenotype

Zebrafish Information Network

Gene name
rbms3
Affected structure
chondrocranium cartilage
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
defense response to tumor cell;positive regulation of gene expression;negative regulation of gene expression;positive regulation of translation;negative regulation of canonical Wnt signaling pathway
Cellular component
nucleus;cytoplasm;cytosol;ribonucleoprotein complex
Molecular function
RNA binding;mRNA 3'-UTR binding;poly(A) binding;poly(U) RNA binding;mRNA 3'-UTR AU-rich region binding